BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24798321)

  • 1. The comparative clinical effectiveness and value of simeprevir and sofosbuvir for chronic hepatitis C virus infection.
    Ollendorf DA; Tice JA; Pearson SD
    JAMA Intern Med; 2014 Jul; 174(7):1170-1. PubMed ID: 24798321
    [No Abstract]   [Full Text] [Related]  

  • 2. The high price of the new hepatitis C virus drugs.
    Steinbrook R; Redberg RF
    JAMA Intern Med; 2014 Jul; 174(7):1172. PubMed ID: 24798183
    [No Abstract]   [Full Text] [Related]  

  • 3. New drugs: simeprevir, sofosbuvir, and dolutegravir sodium.
    Hussar DA; Jin ZJ
    J Am Pharm Assoc (2003); 2014; 54(2):202-7. PubMed ID: 24632934
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new era in therapy of chronic hepatitis C].
    Füessl HS
    MMW Fortschr Med; 2015 Feb; 157(2):38. PubMed ID: 25743515
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic viral hepatitis. Treatment progress, hopes for cures.
    Mayo Clin Health Lett; 2014 Mar; 32(3):4-5. PubMed ID: 24696905
    [No Abstract]   [Full Text] [Related]  

  • 6. [New combination therapy increases chances of recovery].
    Jäger-Becker D
    MMW Fortschr Med; 2015 Feb; 157(3):70. PubMed ID: 25743682
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic hepatitis C. Interferon free therapy also in patients with liver cirrhosis].
    MMW Fortschr Med; 2014 Dec; 156(21-22):97. PubMed ID: 25608420
    [No Abstract]   [Full Text] [Related]  

  • 8. The rapid evolution of treatment strategies for hepatitis C.
    Muir AJ
    Am J Gastroenterol; 2014 May; 109(5):628-35; quiz 636. PubMed ID: 24732866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy spectrum in hepatitis C extended. Newer NS3/4A protease inhibitor in chronic hepatitis C-GT1/4 infection].
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():53. PubMed ID: 25026860
    [No Abstract]   [Full Text] [Related]  

  • 10. Special report: cost-effectiveness studies of new hepatitis C treatments.
    Mark DH;
    Technol Eval Cent Assess Program Exec Summ; 2015 Jan; 29(10):1-3. PubMed ID: 25962188
    [No Abstract]   [Full Text] [Related]  

  • 11. The price of good health.
    Nat Med; 2014 Apr; 20(4):319. PubMed ID: 24710362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis C virus infection in the near future.
    Cheinquer H
    Ann Hepatol; 2013; 12(6):854-9. PubMed ID: 24114813
    [No Abstract]   [Full Text] [Related]  

  • 13. WHO issues guidelines on HCV amid drug cost controversy.
    Slomski A
    JAMA; 2014 Jun; 311(22):2262-3. PubMed ID: 24915242
    [No Abstract]   [Full Text] [Related]  

  • 14. Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients.
    Campos-Varela I; Straley S; Agudelo EZ; Carlson L; Terrault NA
    Liver Transpl; 2015 Feb; 21(2):272-4. PubMed ID: 25332190
    [No Abstract]   [Full Text] [Related]  

  • 15. Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era.
    Berden FA; Kievit W; Baak LC; Bakker CM; Beuers U; Boucher CA; Brouwer JT; Burger DM; van Erpecum KJ; van Hoek B; Hoepelman AI; Honkoop P; Kerbert-Dreteler MJ; de Knegt RJ; Koek GH; van Nieuwkerk CM; van Soest H; Tan AC; Vrolijk JM; Drenth JP
    Neth J Med; 2014 Oct; 72(8):388-400. PubMed ID: 25387551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus: here comes all-oral treatment.
    Dugum M; O'Shea R
    Cleve Clin J Med; 2014 Mar; 81(3):159-72. PubMed ID: 24591471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of drug-drug interactions upon addition of simeprevir- or sofosbuvir-containing treatment to medication profiles of patients with HIV and hepatitis C coinfection.
    Patel N; Nasiri M; Koroglu A; Amin R; McGuey L; McNutt LA; Roman M; Miller C
    AIDS Res Hum Retroviruses; 2015 Feb; 31(2):189-97. PubMed ID: 25432275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in therapy for HIV/hepatitis C virus-coinfected patients in the liver transplant setting.
    Campos-Varela I; Peters MG; Terrault NA
    Clin Infect Dis; 2015 Jan; 60(1):108-16. PubMed ID: 25228702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New hepatitis C treatments: pharmacological considerations and potential for drug interactions].
    Chtioui H; Buclin T; Moradpour D
    Rev Med Suisse; 2014 Sep; 10(440):1600-4, 1606. PubMed ID: 25276998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicine. Hepatitis C can be cured globally, but at what cost?
    Hill A; Cooke G
    Science; 2014 Jul; 345(6193):141-2. PubMed ID: 25013048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.